News for Gen-Probe Incorporated - Google Finance

Medistem, Inc. Appoints Herm Rosenman to Board of Directors

Tue, 21 May 2013 13:01:07 GMT

Medistem, Inc. Appoints Herm Rosenman to Board of Directors
Marketwire (press release) - May 21, 2013

Mr. Rosenman was Senior Vice President and Chief Financial Officer of Gen-Probe, Inc., from 2001, through its IPO in 2002, until its acquisition by Hologic, Inc., in August 2012 for $3.7 billion.

Clinical trial tests targeting prostate cancer treatment

Thu, 23 May 2013 18:24:06 GMT

Clinical trial tests targeting prostate cancer treatment
Sacramento Bee - 20 hours ago

The diagnostic field of use has been licensed to Gen-Probe Inc. Chinnaiyan also has a sponsored research agreement with Gen-Probe.

Global Molecular Diagnostics Market 2012-2016

Mon, 20 May 2013 18:03:18 GMT

Global Molecular Diagnostics Market 2012-2016
Sacramento Bee - May 20, 2013

... Cepheid Inc., Cytometers Inc., Danaher Corp., Diagenode SA, Eli Lilly and Co., Eurogentec S.A., Evotec AG, GE Healthcare Ltd.

Cancer Diagnostic Testing World Markets

Wed, 22 May 2013 13:18:21 GMT

Cancer Diagnostic Testing World Markets
MarketWatch (press release) - May 22, 2013

... Inc. 2206.35 Exiqon 2216.36 Fujirebio Diagnostics, Inc. 2216.37 Gene Logic, Inc. 2226.38 Gen-Probe, Inc. 2226.39 Genomic Health, Inc. 2226.40 Geron Corporation 2236.41 Hologic, Inc. (formerly Cytyc Corporation) 2246.42 Immunicon Corporation (now ...

Trading is cautious

Tue, 21 May 2013 19:02:02 GMT

Trading is cautious
Proactive Investors USA & Canada - May 21, 2013

Medistem, Inc. (PINKS: MEDS) appointed Herm Rosenman to its Board of Directors and Chairman of the Audit Committee. Rosenman was Senior Vice President and Chief Financial Officer of Gen-Probe, Inc., from 2001, through its IPO in 2002, until its ...

Genetic Testing Market Outlook to 2017

Wed, 15 May 2013 15:12:55 GMT

Genetic Testing Market Outlook to 2017
Sacramento Bee - May 15, 2013

The report also profiles the twelve most active genetic testing market players worldwide: Abbott Laboratories, Roche Diagnostics, Myriad Genetics, Life Technologies, Genomic Health, Sequenom, Transgenomic, Dako, Gen-Probe, Quest Diagnostics, Genoptix ...

MedTech Industry Stock Update - May 2013

Wed, 15 May 2013 19:26:09 GMT

MedTech Industry Stock Update - May 2013
Zacks.com - May 15, 2013

The past year also witnessed significant M&A deals, including the acquisition of Switzerland-based Synthes Inc. by Johnson & Johnson (JNJ) for a whopping $19.7 billion, and Gen-Probe Inc. by Hologic (HOLX) for $3.8 billion. Trends over the recent past ...

PerkinElmer, Inc. Market Share Analysis: New Research Report Available at Fast ...

Wed, 08 May 2013 14:32:13 GMT

PerkinElmer, Inc. Market Share Analysis: New Research Report Available at Fast ...
SBWire (press release) - May 8, 2013

... Fisher Scientific Inc., Immucor, Inc., BioPorto Diagnostics A/S, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Qiagen N.V.

DiagnoCure announces presentation on Previstage GCC at the 2013 ASCO ...

Thu, 16 May 2013 11:30:39 GMT

DiagnoCure announces presentation on Previstage GCC at the 2013 ASCO ...
Canada NewsWire (press release) - May 16, 2013

The Corporation has also granted a worldwide exclusive license to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. operating as Hologic Gen-Probe, for the development and commercialization of a prostate cancer test using PCA3, DiagnoCure's ...

Hologic 2nd-Quarter Loss Widened Amid Acquisition-Related Expenses, Other ...

Mon, 06 May 2013 20:40:40 GMT

Hologic 2nd-Quarter Loss Widened Amid Acquisition-Related Expenses, Other ...
Wall Street Journal - May 6, 2013

Hologic, which focuses on products for women's health, in August completed its roughly $3.8 billion acquisition of test-maker Gen-Probe Inc., expanding its offerings to include products for diagnosing sexually transmitted diseases. "The fundamental ...

HOLX Beats Earnings, View Slashed - Analyst Blog - NASDAQ